New York, New York (PRWEB) June 16, 2013
Biomet hip lawsuit claims alleging serious injuries due to the Biomet M2a Magnum Hip Replacement System continue to mount in a federal multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an MDL Statistics Report issued on May 14th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), at least 308 Biomet hip replacement claims have been filed in the federal litigation since it was established in October 2012. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We continue to hear from individuals fitted with metal-on-metal hip implants, including the Biomet M2a Magnum, who allegedly suffered serious complications associated with the failure of their device. It is not surprising that the number of Biomet hip replacement lawsuits filed in this litigation has already surpassed 300,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is actively filing Biomet hip lawsuits in the federal multidistrict litigation, and continues to offer free and confidential case evaluations to individuals who may have been injured by Biomet M2a Magnum implants.
Biomet Hip Replacement Lawsuits
According to court documents, Biomet hip lawsuits allege the metal-on-metal design of the Biomet M2a Magnum implant is prone to wear, and can generate high metal ion levels. This may cause patients to suffer metallosis and other adverse tissue reactions, premature device failure and other complications that necessitate revision surgery to remove and replace the device. When the multidistrict litigation was established by the JPML in October 2011, 66 Biomet hip replacement claims were pending in federal courts throughout the U.S.
The U.S. Food & Drug Administration (FDA) has been investigating metal-on-metal hip implants since February 2011, amid concerns that metal ions shed from the hips can result in metallosis, adverse local tissue reactions, and early failure. In January, the agency issued new guidance for hip replacement patients fitted with these devices that suggested metal ion testing in those experiencing symptoms of hip implant failure. The FDA also said it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which allowed metal-on-metal hips to come to market without first undergoing human clinical trials.*
Biomet M2a Magnum hip recipients who allegedly suffered injuries as a result of the device may be entitled to compensation for their medical expenses, lost wages and pain and suffering. To learn more about the litigation surrounding this and other metal-on-metal hip implants, please visit Bernstein Liebhard LLP’s website, or call one our attorneys today at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Read the full story at http://www.prweb.com/releases/biomet-hip-lawsuit/biomet-m2a-magnum-hip/prweb10837522.htm.
Copyright©2012 Vocus, Inc.
All rights reserved